Quarterly report [Sections 13 or 15(d)]

Note 10 - Share-based Compensation - Schedule of Allocated Expense (Details)

v3.25.2
Note 10 - Share-based Compensation - Schedule of Allocated Expense (Details) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Share-based compensation expense $ 1,669,428 $ 3,376,406 $ 6,567,376 $ 10,417,526
FC2 Female Condom [Member] | Discontinued Operations, Disposed of by Sale [Member]        
Share-based compensation expense, discontinued operations 0 307,721 (10,049) 1,335,287
Selling, General and Administrative Expenses [Member]        
Share-based compensation expense 1,290,912 2,310,153 4,914,586 7,005,004
Research and Development Expense [Member]        
Share-based compensation expense $ 378,516 $ 758,532 $ 1,662,839 $ 2,077,235